Risk management of nutritional supplements in chronic illness: The implications for the care of cancer and depression

Proceedings of the Nutrition Society

Volumn 66, Issue 4, 2007, Pages 483-492

  Werneke, Ursula ^a  

^a VRINNEVI HOSPITAL   (Sweden)

Author keywords

Cancer; Depression; Nutritional supplements; Risk management

Indexed keywords

5 HYDROXYTRYPTOPHAN; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; BETA CAROTENE; CETUXIMAB; CISPLATIN; CYCLOSPORIN; DOXORUBICIN; ESTROGEN; FLUOROURACIL; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOSITOL; IRINOTECAN; METHOTREXATE; OMEGA 3 FATTY ACID; PACLITAXEL DERIVATIVE; RETINOL; S ADENOSYLMETHIONINE; SELENIUM; TETRACYCLINE; TRYPTOPHAN; UBIQUINONE; UNINDEXED DRUG; WARFARIN;

ARTICLE; BONE DENSITY; BONE DISEASE; BONE MARROW STIMULATION; CANCER; CANCER RADIOTHERAPY; CARDIOTOXICITY; CHRONIC DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; COLORECTAL CANCER; COMA; DELIRIUM; DEPRESSION; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; DRUG INDUCED DISEASE; DRUG SAFETY; EOSINOPHILIA MYALGIA SYNDROME; HEALTH CARE; HUMAN; HYPOTENSION; HYPOTHYROIDISM; INTERPERSONAL COMMUNICATION; INTRACRANIAL HYPERTENSION; IRRITABILITY; KIDNEY INJURY; LEUKOPLAKIA; LIVER TOXICITY; MANIA; MEDICOLEGAL ASPECT; MEDLINE; MORTALITY; NAIL DISEASE; NAUSEA; NONHUMAN; PATIENT ATTITUDE; PROSTATE CANCER; RISK MANAGEMENT; SCURVY; SEROTONIN SYNDROME; SIDE EFFECT; VOMITING; WEIGHT REDUCTION;

CHRONIC DISEASE; COMPLEMENTARY THERAPIES; CONSUMER PRODUCT SAFETY; DEPRESSION; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; HUMANS; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; RISK MANAGEMENT; TREATMENT OUTCOME;

EID: 35548983144     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665107005800     Document Type: Article

References (102)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR & Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs and pattern of use. N Engl J Med 328, 246-252.
2. Ernst E & Cassileth BR (1999) How useful are unconventional cancer treatments? Eur J Cancer 35, 1608-1613.
3. Werneke U, Ladenheim D & McCarthy T (2004) Complementary alternative medicine for cancer: a review of effectiveness and safety. Cancer Ther 2B, 475-500.
4. Werneke U, Turner T & Priebe S (2006) Complementary alternative medicine in psychiatry: a review of effectiveness and safety. Br J Psych 188, 109-121.
5. Bernstein BJ & Grasso T (2001) Prevalence of complementary and alternative medicine use in cancer patients. Oncology 15, 1267-1272.
6. Unutzer J, Klap R, Sturm R, Young AS, Marmon T, Shatkin J & Wells KB (2000) Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry 157, 1851-1857.
7. Moorey S & Greer S (2002) Cognitive Behaviour Therapy for People with Cancer, 2nd ed., pp. 3-24. Oxford: Oxford University Press.
8. Burns D (1999) Feeling Good, 2nd ed., pp. 19-49. London: Harper Collins Publishers.
9. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. http://www.naturaldatabase.com
10. Labriola D & Livingston R (1999) Possible interactions between dietary antioxidants and chemotherapy. Oncology 13, 1003-1008.
11. Pommier YG, Goldwasser F & Strumberg D (2001) Topoisomerase II inhibitors: epipodophyllotoxins, acridines, ellipticines and bisdioxopiperazines. In Cancer Chemotherapy and Biotherapy, 3rd ed., pp. 539-578 [BA Chabner and D Logo, editors]. Philadelphia, PA: Lippincott, Williams & Wilkins.
12. Drake EN (2006) Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses 67, 318-322.
13. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P & ATBC Study Group (2003) Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 23, 476-485.
14. Alpha-Tocopherol, Beta-Carotene Prevention Study Group (1994) The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330, 1029-1035.
15. Turner EH & Blackwell AD (2005) 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Med Hypothesis 65, 138-144.
16. Shaw K, Turner J & Del Mar C (2002) Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis. Aust N Z J Psychiatry 36, 488-491.
17. Bottiglieri T (2002) S-Adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule. Am J Clin Nutr 76, 1151S-1157S.
18. Morris M, Fava M & Jaques PF (2003) Depression and folate status in the US population. Psychothep Psychosom 72, 80-87.
19. Schreiber G & Avissar S (2005) Regulators of G-protein-coupled receptor-G-protein coupling: antidepressants mechanism of action. Expert Rev Neurother 7, 75-84.
20. Hahn CG, Umapathy, Wang HY, Koneru R, Levinson DF & Friedman E (2005) Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 39, 355-363.
21. Bressa GM (1994) S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand 154, Suppl., 7-14.
22. Delle Chiaie R, Pancheri P & Scapicchio P (2002) Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr 76, 1172S-1176S.
23. Taylor MJ, Carney S, Geddes J & Goodwin G (2003) Folate for depressive disorders. Cochrane Database of Systematic Reviews, issue 2, art no. CD003390. Chichester, West Sussex: John Wiley & Sons Ltd.
24. Hallahan B & Garland MR (2005) Essential fatty acids and mental health. Br J Psychiatry 186, 275-277.
25. Freeman MP, Hibbeln JR, Wisner KL et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954-1967.
26. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'inositol'. http:\www.naturaldatabase.com
27. Dursun SM, Blackburn JR & Kutcher SP (2001) An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap. Med Hypothesis 56, 235-243.
28. Cheng L, Lumb M, Polgar L & Mudge AW (2005) How can the mood stabilizer VPA limit both mania and depression? Mol Cell Neurosci 29, 155-161.
29. Taylor MJ, Wilder H, Bhagwagar Z & Geddes J (2004) Inositol for depressive disorders. Cochrane Database of Systematic Reviews, issue 1, art no. CD004049. Chichester, West Sussex: John Wiley & Sons Ltd.
30. Levine J (1997) Controlled trials of inositol in psychiatry. Eur Neuropsychopharmacol 7, 147-155.
31. Nierenberg AA, Ostacher MJ, Calabrese JR et al. (2006) Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 163, 210-216.
32. Eden Evins A, Demopulos C, Yovel I, Culhane M, Ogutha J, Grandin LD, Nierenberg AA & Sachs GS (2006) Inositol augmentation of lithium or valproate for bipolar depression. Bipolar Disord 8, 168-174.
33. Rayman MP (2000) The importance of selenium to human health. Lancet 356, 233-241.
34. Castano A, Ayala A, Rodriguez-Gomez JA, Herrera AJ, Cano J & Machado A (1997) Low selenium diet increases the dopamine turnover in prefrontal cortex of the rat. Neurochem Int 30, 549-555.
35. Hawkes WC & Hornbostel L (1996) Effects of dietary selenium on mood in healthy men living in a metabolic research unit. Biol Psychiatry 39, 121-128.
36. Benton D & Cook R (1991) The impact of selenium supplementation on mood. Biol Psychiatry 29, 1092-1098.
37. Rayman M, Thompson A, Warren-Perry M, Galassini R, Catterick J, Hall E, Lawrence D & Bliss J (2006) Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry 59, 147-154.
38. Hayden KM, Welsh-Bohmer KA, Wengreen HJ, Zandi P, Lyketsos C & Breitner J (2007) Risk of mortality with vitamin E supplements: the Cache County study. Am J Med 120, 180-184.
39. Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J & Albanes D (2006) Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 84, 959-960.
40. Jacobs EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, Jonas CR, Rodriguez C, Calle EE & Thun MJ (2002) Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol 156, 1002-1010.
41. Dagnelie PC, Schuurman AG, Goldbohm RA & Van den Brandt PA (2004) Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93, 1139-1150.
42. Longnecker MP, Martin-Moreno JM, Knekt P, Nomura AM, Schober SE, Stahelin HB, Wald NJ, Gey KF & Willett WC (1992) Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. J Natl Cancer Inst 84, 430-435.
43. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG & Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842-857.
44. Werneke U, Earl J, Seydel C, Horn O, Crichton P & Fannon D (2004) Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 90, 408-413.
45. Expert Group on Vitamins and Minerals (2003) Safe upper levels for vitamins and minerals. http://www.food.gov.uk/multimedia/pdfs/vitmin2003.pdf
46. Sketris IS, Farmer PS & Fraser A (1984) Effect of vitamin C on the excretion of methotrexate. Cancer Treat Rep 68, 446-447.
47. Bays HE (2006) Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 99, 35C-43C.
48. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'L-tryptophan, 5-hydroxytryptophan'. http://www.naturaldatabase.com
49. Simat TJ, Kleeberg KK, Muller B & Sierts A (1999) Synthesis, formation, and occurrence of contaminants in biotechnologically manufactured L-tryptophan. Adv Exp Med Biol 467, 469-480.
50. Omenn GS, Goodman GE, Thornquist MD et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334, 1150-1155.
51. Alija AJ, Bresgen N, Sommerburg O, Siems W & Eckl PM (2004) Cytotoxic and genotoxic effects of beta-carotene breakdown products on primary rat hepatocytes. Carcinogenesis 25, 827-831.
52. Kelemen LE (2006) The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 119, 243-250.
53. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'folic acid'. http://www.naturaldatabase.com
54. Agostinelli E & Seiler N (2006) Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications. Amino Acids 31, 341-345.
55. D'Andrea GM (2005) Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55, 319-321.
56. Calvert H (2002) Folate status and the safety profile of antifolates. Semin Oncol 2, Suppl. 5, 3-7.
57. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK & Marangell LB (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56, 407-412.
58. Harris WS (2007) Expert opinion: omega-3 fatty acids and bleeding - cause for concern? Am J Cardiol 99, 44C-46C.
59. McClaskey EM & Michalets E (2007) Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: case report and review of the literature. Pharmacotherapy 27, 152-160.
60. Booth SL, Golly I, Sacheck JM, Roubenoff R, Dallal GE, Hamada K & Blumberg JB (2004) Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am J Clin Nutr 80, 143-148.
61. Tornwall ME, Virtamo J, Korhonen PA, Virtanen MJ, Albanes D & Huttunen JK (2004) Postintervention effect of alpha tocopherol and beta carotene on different strokes: a 6-year follow-up of the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. Stroke 35, 1908-1913.
62. Nieuwstraten C, Labiris NR & Holbrook A (2006) Systematic overview of drug interactions with antidepressant medications. Can J Psychiatry 51, 300-316.
63. Bryant SM & Kolodchak J (2004) Serotonin syndrome resulting from a herbal detox cocktail. Am J Emerg Med 22, 625-626.
64. Friedel HA, Goa KL & Benfield P (1989) S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 38, 389-416.
65. Mischoulon D & Fava M (2002) Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 76, 1158S-1161S.
66. Jones D & Story DA (2005) Serotonin syndrome and the anaesthetist. Anaesth Intensive Care 33, 181-187.
67. Pariante CM, Orru MG, Carpiniello B & Rudas N (1995) Multiple sclerosis and major depression resistant to treatment. Case of a patient with antidepressive therapy-induced mood disorder, associated with manic features. Clin Ther 146, 449-452.
68. Patterson BD & Srisopark MM (1989) Severe anorexia and possible psychosis or hypomania after trazodone-tryptophan treatment of aggression. Lancet i, 1017.
69. Goff DC (1985) Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor. Am J Psychiatry 142, 1487-1488.
70. Cohen MH & Eisenberg DM (2002) Potential physician malpractice liability associated with complementary and integrative medicinal therapies. Ann Intern Med 136, 596-603.
71. Wikipedia (2007) Paracelsus. http://en.wikipedia.org/wiki/Paracelsus
72. General Medical Council (2006) Good practice for prescribing medicines. http://www.gmc-uk.org/guidance/current/library/prescriptions (accessed May 2006).
73. Bjelakovic G, Nikolova D, Simonetti RG & Gluud C (2004) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364, 1219-1228.
74. Lodi G, Sardella A, Bez C, Demarosi F & Carrassi A (2006) Interventions for treating oral leukoplakia. Cochrane Database of Systematic Reviews, issue 4, art. no. CD001829. Chichester, West Sussex: John Wiley & Sons Ltd.
75. Coulter ID, Hardy ML, Morton SC, Hilton LG, Tu W, Valentine D & Shekelle PG (2006) Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer. J Gen Intern Med 21, 735-744.
76. Gandini S, Merzenich H, Robertson C & Boyle P (2000) Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 36, 636-646.
77. Heinonen OP, Albanes D, Virtamo J et al. (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90, 440-446.
78. Wright ME, Virtamo J, Hartman AM, Pietinen P, Edwards BK, Taylor PR, Huttunen JK & Albanes D (2007) Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial. Cancer 109, 891-898.
79. Etminan M, FitzGerald JM, Gleave M & Chambers K (2005) Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 16, 1125-1131.
80. Roffe L, Schmidt K & Ernst E (2004) Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: a systematic review. J Clin Oncol 22, 4418-4424.
81. Duffield-Lillico AJ, Slate EH, Reid ME et al. (2003) Selenium supplementation and secondary prevention of non-melanoma skin cancer in a randomized trial. J Natl Cancer Inst 95, 1477-1481.
82. Therapeutic Research Faculty (2007) Natural Medicines Comprehensive Database. Key word search 'selenium'. http://www.naturaldatabase.com
83. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'vitamin A'. http://www.naturaldatabase.com
84. Nollevaux MC, Guiot Y, Horsmans Y, Leclercq I, Rahier J, Geubel AP & Sempoux C (2006) Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption. Liver Int 26, 182-186.
85. Maddrey WC (2005) Drug-induced hepatotoxicity. J Clin Gastroenterol 39, Suppl. 2, S83-S89.
86. Page C, Curtis M, Walker M & Hoffman B (2006) Integrated Pharmacology, 2nd ed., pp. 589-608. Oxford: Mosby Elsevier.
87. Friedman DI (2005) Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 6, 29-37.
88. Fraunfelder FW & Fraunfelder FT (2004) Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension. J Neuroophthalmol 24, 214-216.
89. Danesi F, Malaguti M, Nunzio MD, Maranesi M, Biagi PL & Bordoni A (2006) Counteraction of adriamycin-induced oxidative damage in rat heart by selenium dietary supplementation. J Agric Food Chem 22, 1203-1208.
90. Fakih M, Cao S, Durrani FA & Rustum YM (2005) Selenium protects against toxicity induced by anticancer drugs and augments antitumor activity: a highly selective, new, and novel approach for the treatment of solid tumors. Clin Colorectal Cancer 5, 132-135.
91. Azrak RG, Cao S, Pendyala L, Durrani F, Fakih M, Combs G, Prey J, Smith P & Rustum Y (2007) Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Biochem Pharmacol 73, 1280-1287.
92. Altundag K, Silay YS, Altundag O, Yigitbasi OG, Gundeslioglu O & Gunduz M (2005) Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients. Med Hypotheses 64, 1162-1165.
93. Kohrle J (2005) Selenium and the control of thyroid hormone metabolism. Thyroid 15, 841-853.
94. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'vitamin C'. http://www.naturaldatabase.com
95. Pace A, Savarese A, Picardo M et al. (2003) Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21, 927-931.
96. Sokol RJ, Johnson KE, Karrer FM, Narkewicz MR, Smith D & Kam I (1991) Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet 338, 212-214.
97. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'vitamin E'. http://www.naturaldatabase.com
98. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'beta-carotene'. http://www.naturaldatabase.com
99. Therapeutic Research Faculty (2007) Natural medicines comprehensive database. Key word search 'co-enzyme Q10'. http://www.naturaldatabase.com
100. Storelli MM, Storelli A & Marcotrigiano GO (2004) Polychlorinated biphenyls, hexachlorobenzene, hexachlorocyclohexane isomers, and pesticide organochlorine residues in cod-liver oil dietary supplements. J Food Prot 67, 1787-1791.
101. Koller H, Luley C, Klein B, Baum H & Biesalski HK (1989) Contaminating substances in 22 over-the-counter fish oil and cod liver oil preparations: cholesterol, heavy metals and vitamin A. Z Ernahrungswiss 28, 76-83.
102. Levine J, Barak Y, Kofman O & Belmaker RH (1995) Follow-up and relapse analysis of an inositol study of depression. Isr J Psychiatry Relat Sci 32, 14-21.